UNC9036
UNC9036 is a STING PROTAC degrader with a DC50 value of 227 nM. UNC9036 binds to and activates STING, recruits the VHL E3 ligase to target phosphorylated STING for ubiquitination and proteasomal degradation. UNC9036 inhibits downstream innate immune signaling events triggered by cytoplasmic DNA sensing, including IRF3 phosphorylation. UNC9036 reduces the antiviral response of cells infected with HSV-1. UNC9036 can be used in the research of renal cell carcinoma.
(Pink: STING ligand (HY-184545); Blue: VHL ligand (HY-138678B); Black: linker (HY-W105727)).
For research use only. We do not sell to patients.
- CAS No.: 3094059-54-5
- Formula: C73H95N17O11S
- Molecular Weight:1418.71
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
VHL |
HSV-1 |
In Vitro
UNC9036 (0-31.6 μM; 0-24 h) potently degrades STING in Caki-1 renal cell carcinoma cells with a DC50 of 227 nM and achieves 91.68% maximal degradation after 24 h, with significant degradation detectable within 8 h[1].
UNC9036 (5 μM; 24 h) degrades wild-type, cGAMP binding-deficient (R238A), and TBK1 phosphorylation-deficient (S366A) STING, but does not degrade trafficking-deficient (EDAA) or palmitoylation/activation-deficient (CACA) STING in Caki-1 renal cell carcinoma cells[1].
UNC9036 (0.316 μM; 6 h) dampens STING-mediated DNA sensing signaling in Caki-1 renal cell carcinoma cells by reducing STING protein levels and suppressing ISD90-induced and 2'3'-cGAMP-induced IRF3 phosphorylation, while having minimal effect on poly(I:C)-induced IRF3 phosphorylation[1].
UNC9036 (3 μM; 16 h) treatment significantly reduces the anti-viral response in Caki-1 renal cell carcinoma cells infected with HSV-1, as evidenced by increased viral titers compared to DMSO control[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Caki-1 renal cell carcinoma cells
-
Concentration:0-31.6 μM (dose-response); 1 μM (time-course)
-
Incubation Time:24 h (dose-response); 0-24 h (time-course)
-
Result:Triggered dose-dependent and time-dependent degradation of STING protein.
Achieved a DC50 of 227 nM and a Dmax of 91.68% after 24 h treatment.
Induced significant STING degradation within 8 h of treatment with 1 μM.
-
Cell Line:Caki-1 renal cell carcinoma cells (transfected with Flag-tagged wild-type or mutant STING)
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Degraded wild-type STING, R238A (2'3'-cGAMP binding-deficient) mutant, and S366A (TBK1 phosphorylation-deficient) mutant.
Failed to degrade EDAA (trafficking-deficient) mutant and CACA (palmitoylation/activation-deficient) mutant.
-
Cell Line:Caki-1 renal cell carcinoma cells
-
Concentration:0.316 μM UNC9036; 5 μg/mL ISD90, 5 μg/mL 2'3'-cGAMP, 5 μg/mL poly(I:C)
-
Incubation Time:6 h pre-incubation; 0-6 h stimulation
-
Result:Reduced STING protein abundance.
Suppressed ISD90-induced and 2'3'-cGAMP-induced phosphorylated IRF3 signals.
Minimally affected poly(I:C)-induced phosphorylated IRF3 signals.
Chemical Information
-
CAS No. 3094059-54-5
-
Molecular Weight 1418.71
-
Formula C73H95N17O11S
-
SMILES
O=C(NCCCCCCCCC(N[C@@H](C(N1[C@H](C(NCC2=CC=C(C=C2)C3=C(C)N=CS3)=O)C[C@H](C1)O)=O)C(C)(C)C)=O)C4=CC5=C(C(OC)=C4)N(C/C=C/CN6C(NC(C7=CC(C)=NN7CC)=O)=NC8=C6C(OCCCN9CCOCC9)=CC(C(N)=O)=C8)C(NC(C%10=CC(C)=NN%10CC)=O)=N5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)